RituximabVarious infusion-related reactions: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1853卷 / 1期
关键词：
D O I：
10.1007/s40278-021-95289-y
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：423 / 423
相关论文
共 50 条
  • [31] Rituximab infusion-related reactions: clinical prediction model
    Reactions Weekly, 2017, 1640 (1) : 11 - 11
  • [32] Infusion-related reactions to rituximab: frequency, mechanisms and predictors
    Paul, Franciane
    Cartron, Guillaume
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (04) : 383 - 389
  • [33] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2016, 1583 (1) : 955 - 955
  • [34] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2013, 1464 (1) : 35 - 35
  • [35] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2018, 1693 (1) : 451 - 451
  • [36] Eravacycline infusion-related hypoesthesia: A case report
    Miller, R. Briley
    McClure, Kinsey M.
    Stewart, Robby G.
    Shealy, Stephanie C.
    Brown, Krishnan
    Bookstaver, P. Brandon
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (14) : 1146 - 1150
  • [37] ETOPOSIDE INFUSION-RELATED REACTIONS IN PEDIATRIC ONCOLOGY PATIENTS
    Rayar, M.
    Dupuis, L.
    Atkinson, A.
    Shaikh, F.
    Taylor, T.
    Ross, S.
    Alexander, S.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S352 - S353
  • [38] Predicting the risk of infusion-related reactions in ocrelizumab treatment
    Schoof, Lisa
    Hogenboom, Laura
    Mulder, Thom
    van Kempen, Zoe
    van Oosten, Bob
    Killestein, Joep
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1002 - 1002
  • [39] Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab
    Moore, Donald C.
    Arnall, Justin R.
    Thompson, Daniel L.
    Martin, Allison L.
    Robinson, Jordan
    Ndiaye, Ami
    Paul, Barry
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : E777 - E781
  • [40] Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody): Seven Case Reports
    Liang, Weiting
    Guo, Zhijun
    Zhang, Yunhui
    Yang, Ning
    Guo, Chenchen
    Liu, Tao
    Huang, Hongbing
    Chen, Zhuojia
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 361 - 369
12345